-
Product Insights
Acute Liver Failure – Drugs In Development, 2023
Global Markets Direct’s, ‘Acute Liver Failure - Drugs In Development, 2023’, provides an overview of the Acute Liver Failure pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acute Liver Failure, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Liver Failure (Hepatic Insufficiency) – Drugs In Development, 2023
Global Markets Direct’s, ‘Liver Failure (Hepatic Insufficiency) - Drugs In Development, 2023’, provides an overview of the Liver Failure (Hepatic Insufficiency) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Liver Failure (Hepatic Insufficiency), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Ebolavirus Infections (Ebola Hemorrhagic Fever) – Drugs In Development, 2023
Global Markets Direct’s, ‘Ebolavirus Infections (Ebola Hemorrhagic Fever) - Drugs In Development, 2023’, provides an overview of the Ebolavirus Infections (Ebola Hemorrhagic Fever) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Ebolavirus Infections (Ebola Hemorrhagic Fever), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Respiratory Syncytial Virus (RSV) Infections – Drugs In Development, 2023
Global Markets Direct’s, ‘Respiratory Syncytial Virus (RSV) Infections - Drugs In Development, 2023’, provides an overview of the Respiratory Syncytial Virus (RSV) Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Respiratory Syncytial Virus (RSV) Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Influenzavirus A Infections – Drugs In Development, 2023
Global Markets Direct’s, ‘Influenzavirus A Infections - Drugs In Development, 2023’, provides an overview of the Influenzavirus A Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Influenzavirus A Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Orthopedic Bone Cement and Casting Materials Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Orthopedic Bone Cement and Casting Materials Pipeline Market Report Overview Bone cement and casting materials are used to fix bone fractures or as a complement to other devices in procedures such as joint reconstruction and trauma fixation. The Orthopedic Bone Cement and Casting Materials pipeline market research report provides comprehensive information about the Orthopedic Bone Cement and Casting Materials pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MRT-2359 in Non-Small Cell Lung Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. MRT-2359 in Non-Small Cell Lung Cancer Drug Details: MRT-2359 is under development for the treatment...
-
Product Insights
Thien Phu 2 Wind Farm
Thien Phu 2 Wind Farm is an offshore wind project located in South China Sea, Vietnam. The project is owned by Lee & Lee; Queen Capital Finance Ltd and is developed by Thien Phu Energy Investment Corp. The project is at the permitting stage. Empower your strategies with our Thien Phu 2 Wind Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2...
-
Product Insights
Spinal Fusion Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Spinal Fusion Pipeline Market Report Overview Spinal Fusion procedures are mainly performed on the cervical and thoracolumbar regions. Spinal fusion is a surgical procedure that involves joining two vertebrae in the spine to form a single solid bone, with the involvement of certain devices, to relieve pain. Conventional and Minimally Invasive Surgery (MIS) methods are used to perform Spinal Fusion. Conventional methods include all open surgical methods that are used for performing spinal procedures. The Spinal Fusion pipeline market research...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MRT-2359 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MRT-2359 in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MRT-2359 in Solid Tumor Drug Details: MRT-2359 is under development for the...